Bridgebio Pharma Inc
(BBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 393,949 | 180,347 | 378,420 | 471,176 | 356,082 |
| Marketable Securities | 442,891 | 419,264 | 459,243 | 447,942 | 251,011 |
| Receivables | 19,749 | 8,172 | 45,538 | 462 | N/A |
| TOTAL | $888,858 | $639,710 | $909,871 | $945,114 | $642,824 |
| Non-Current Assets | |||||
| PPE Net | 30,066 | 27,741 | 26,272 | 22,816 | 20,325 |
| Investments And Advances | 0 | 17,707 | 79,582 | 82,202 | 0 |
| Intangibles | 44,934 | 46,204 | 0 | 0 | 0 |
| Other Non-Current Assets | 48,934 | 50,162 | 65,761 | 43,176 | 40,439 |
| TOTAL | $123,934 | $141,814 | $171,615 | $148,194 | $60,764 |
| Total Assets | $1,012,792 | $781,524 | $1,081,486 | $1,093,308 | $703,588 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 3,646 | 1,458 |
| Accounts payable and accrued liabilities | 11,884 | 12,035 | 22,329 | 10,340 | 8,945 |
| Accrued Expenses | 87,965 | 64,181 | 83,863 | 58,682 | 62,551 |
| Other current liabilities | N/A | N/A | N/A | N/A | 5,550 |
| TOTAL | $135,069 | $95,823 | $131,909 | $94,729 | $95,648 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,703,805 | 1,375,314 | 1,373,915 | 1,361,199 | 475,857 |
| Other Non-Current Liabilities | 46,025 | 54,309 | 38,878 | 34,748 | 40,871 |
| TOTAL | $1,744,725 | $1,424,542 | $1,407,067 | $1,387,944 | $501,684 |
| Total Liabilities | $1,879,794 | $1,520,365 | $1,538,976 | $1,482,673 | $597,332 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 147,608 | 147,167 | 149,765 | 149,284 | 148,956 |
| Common Shares | 154 | 153 | 153 | 152 | 125 |
| Retained earnings | -1,436,966 | -1,289,789 | -1,133,854 | -1,037,506 | -888,755 |
| Other shareholders' equity | 3,280 | 4,575 | 6,532 | 5,872 | 48,542 |
| TOTAL | $-867,002 | $-738,841 | $-457,490 | $-389,365 | $106,256 |
| Total Liabilities And Equity | $1,012,792 | $781,524 | $1,081,486 | $1,093,308 | $703,588 |